Balancing the costs with the benefits
Weight loss can mean better health and lower costs for plan sponsors and members alike. Investing in these expensive, but effective drugs is a balancing act – especially when more than half of the U.S. adult population is eligible for them. Get insights on how to manage costs for the most talked-about drugs in pharmacy.
Preparing your plan for the GLP-1 era
After revolutionizing care for diabetes and weight loss, GLP-1 drugs are being eyed for more. Create a strategy today as these drugs continue to evolve and expand indications.
Weighty issue: How to contain GLP-1 costs
Get strategies for handling the new anti-obesity medications.
GLP-1 agonists: A new class of weight loss medications
In this conversation, discover how new weight loss drugs like Wegovy are changing obesity management and their connection to diabetes.
There’s No Outrunning the GLP-1 Wave
Get the latest on weight loss management, GLP-1s and GIPs in this on-demand webinar.
Pharmacy Insights Podcast
Listen to our resident experts discuss critical industry challenges and the solutions you need to control rising drug costs.
The new drugs plan sponsors need to watch for
See which trends to consider when assessing the pharmacy benefit, which new drugs may be flying under the radar and what's coming.
How to push back on 3 key pharmacy headwinds
Innovative formulary structures and clinical programs can help plan sponsors meet the challenge of expensive orphan, biologic and GLP-1 drugs.